Member Info for Tatty99

PHE net assets are just under £9m. Mcap is now £75m. Based on available numbers alone arguably overvalued. Based on potential revenues, who knows? You can't just pluck a valuation number out of thin air. There has to be some underlying arithmetic or comparable exercise to which someone then adds an opinion.

As the euphoria of two back to back RNSs dies down, the patents are not going to speed up the actual construction of the eagerly awaited test unit. We're still a long way off a first commercial scale unit too. A lot more patience needed still.

Yes it sounds like someone was made an offer they couldn’t refuse!

I do wonder if the established product suppliers would do anything to destroy a future competitor such as Dest? It is puzzling why the mcap continues to fall, when the prospects and broker forecasts are so positive.

Positive RNS but intrigued as to why Newmont want to offload their 70% interest if Havieron is such a glittering asset, and they are still funding the continuing mine development.

CCA is for non profit organisations?

I recall one broker forecast sp of around 275p a few months ago. I wonder what they forecast now?

Disaster.

Is this heading for the graveyard of many previoud doomed pharma starts ups?

Pax I asked this very same question at the AGM last year and was given a vague reply/excuse about 'difficult to plan when you're a start up". Not a great answer. They could only talk in terms of yearly quarters and half years. It made me recall the old saying 'Fail to plan? So plan to fail". Since then of course the reaction chamber maker went bust and the ex directors challenge the patent.

I'm still not convinced the technology will work at scale until at least the demo is built and, as you imply, when is that going to be? Originally 'estimated' to be up and running by now i.e. end of first quarter 2024.

What's happening in Australia I wonder? What 'plans' are in place there? They are going to need a new can to kick down the road as the current one is too beaten up.

My concern is why would anyone choose xf73 as opposed to any of the current existing and competing products? Sometimes the best product loses out to better marketing.

Some kind of update from the company is overdue in the light of such a huge drop since last update.

Based on the recorded volumes of shares sold, (150k), talk of a seller causing this drop is somewhat hard to believe.

Given the scale of the opportunities, the Board has decided to raise additional capital to capitalise on these growth opportunities and build shareholder value

So the sp drops 12%. Some shareholder value!

And any feedback from the conference in Barcelona on the 18th?

Reads very positive but no money mentioned.

Shaun describes a great asset so why is the SP so low? I still worry about the aquifer issue.

Very bad to see such massive drops without any kind of explanation or assurance. And if communications are being ignored what's going on inside Destiny. Does the broker still have an SP target of 279 give the current valuation I wonder?

A six figure payemt to be made every 12 months nail product launch? How many 12 month periods are they expecting to wait until product launch? What payments would be expected after product launch?

…….comes the dumping. Be careful.

Paul sounded very confident and honest. Interesting to see PHE have gone back to the original strategy of licencing. I suppose without a mountain of cash it makes sense.